Barriers and facilitators to deprescribing of cardiovascular medications: a systematic review
Objective To synthesise the current knowledge on barriers and facilitators to deprescribing cardiovascular medications (CVMs) at the levels of patients, informal caregivers and healthcare providers (HCPs).Design/setting We conducted a systematic review of studies exploring/assessing patient, informa...
Saved in:
| Main Authors: | Nicolas Rodondi, Carole Elodie Aubert, Laureline Brunner |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2022-12-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/12/12/e061686.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Physician perspectives on statin continuation and discontinuation in older adults in primary cardiovascular prevention: a qualitative methods study
by: Claudio Schneider, et al.
Published: (2024-10-01) -
Barriers and facilitators to antidepressant deprescribing – A qualitative interview study with general practitioners in Germany
by: Jochen Vukas, et al.
Published: (2025-12-01) -
Deprescribing: An umbrella review
by: Japelj Nuša, et al.
Published: (2024-06-01) -
Enablers and barriers to community pharmacists' readiness to implement deprescribing of inappropriate medications for older adults in Qatar.
by: Marwa Elshazly, et al.
Published: (2025-01-01) -
Deprescribing interventions in older adults: An overview of systematic reviews.
by: Shiyun Chua, et al.
Published: (2024-01-01)